Description |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Filgrastim 300mg |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Sandoz |
|
Product Type |
Product Size |
Injection
|
1'S |
Product Company |
Nector pharma
|
Pegfilgrastim 6mg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Carboplatin 150mg/15ml |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Himmel Pharma |
|
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Mass Pharma |
Amlodipine 5mg
|
Content | Filgrastim is a drug that has been used successfully for cancer patients to stimulate the growth of the white blood cells | Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | "
Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor analog filgrastim. It serves to stimulate the production of white blood cells.
| Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
| Gemcitabine is a cytidine analog with two fluorine atoms.As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells. | Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
|
Reviews
There are no reviews yet.